Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP381099.RAQOc6LFq5nEmYPmi-vT0ENJhnMn0NrHla0qwKj8_2Tf8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP381099.RAQOc6LFq5nEmYPmi-vT0ENJhnMn0NrHla0qwKj8_2Tf8130_assertion type Assertion NP381099.RAQOc6LFq5nEmYPmi-vT0ENJhnMn0NrHla0qwKj8_2Tf8130_head.
- NP381099.RAQOc6LFq5nEmYPmi-vT0ENJhnMn0NrHla0qwKj8_2Tf8130_assertion description "[High phosphatidylinositol-3-kinase-mediated signaling activity of the primary tumor, rather than KRAS/BRAF mutation status, was identified as a hallmark of poor metastasis-free survival in patients with locally advanced rectal cancer undergoing radical treatment of the pelvic cavity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381099.RAQOc6LFq5nEmYPmi-vT0ENJhnMn0NrHla0qwKj8_2Tf8130_provenance.
- NP381099.RAQOc6LFq5nEmYPmi-vT0ENJhnMn0NrHla0qwKj8_2Tf8130_assertion evidence source_evidence_literature NP381099.RAQOc6LFq5nEmYPmi-vT0ENJhnMn0NrHla0qwKj8_2Tf8130_provenance.
- NP381099.RAQOc6LFq5nEmYPmi-vT0ENJhnMn0NrHla0qwKj8_2Tf8130_assertion SIO_000772 23226389 NP381099.RAQOc6LFq5nEmYPmi-vT0ENJhnMn0NrHla0qwKj8_2Tf8130_provenance.
- NP381099.RAQOc6LFq5nEmYPmi-vT0ENJhnMn0NrHla0qwKj8_2Tf8130_assertion wasDerivedFrom befree-20140225 NP381099.RAQOc6LFq5nEmYPmi-vT0ENJhnMn0NrHla0qwKj8_2Tf8130_provenance.
- NP381099.RAQOc6LFq5nEmYPmi-vT0ENJhnMn0NrHla0qwKj8_2Tf8130_assertion wasGeneratedBy ECO_0000203 NP381099.RAQOc6LFq5nEmYPmi-vT0ENJhnMn0NrHla0qwKj8_2Tf8130_provenance.